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LETTERS TO THE EDITOR 
almost no domestic facilities could be of some impor- 
tance since serological markers were low in children 
under 1 year of age, and rose sharply in the 1-4 and 
5-14 year age-groups. Nevertheless, it is also possible 
that some children were perinatally infected and that 
their mothers subsequently became negative for HBeAg 
since the prevalence of HBeAg decliness with age. The 
low prevalence of HBeAg may reflect a favorable progno- 
sis for chronic liver disease. However, the absence of 
this marker may not mean absence of HBV replication 
but merely reflects a lower level of viral replication (4). 
We conclude that all seronegative Kurdish immi- 
grants, especially children, and ail newborns should be 
vaccinated against HBV. 
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Synthesis and clearance of atria1 natriuretic factor in cirrhosis 
The physiology and pathophysiology of atria1 natri- 
uretic factor (ANF) clearance has become the subject of 
increasing interest (1,2). In their recent study Moreau 
et al. (3) found a negative correlation between liver 
function as indicated by serum bilirubin concentrations 
and splanchnic ANF extraction. Since two of their 
patients with severe liver failure had renal, hepatic or 
forearm venous concentrations that were higher than 
the arterial ANF concentrations, the authors conclude 
that liver failure may limit ANF clearance through the 
induction of ANF synthesis or other mechanism and 
lead to increased ANF release. However, the data pre- 
sented in this paper show that there is no correlation 
between peripheral arterial or venous ANF plasma levels 
and the severity of liver disease as indicated by the 
Child-Pugh score. Furthermore, patients with an ICG 
clearance of < 10% and presumably a very poor splanch- 
nit clearance exhibit both low renal and pulmonary 
ANF clearances and low renal, pulmonary and forearm 
ANF extraction ratios. Remarkably, three of these 
patients also exhibit both very low peripheral venous 
and arterial ANF concentrations. Therefore the data of 
Moreau and colleagues seem to indicate that some 
patients with severe cirrhosis exhibit a decrease in ANF 
synthesis which is possibly even more marked than the 
decreased ANF clearance rates which result in low 
peripheral venous concentrations. This is an interesting 
finding and might support our hypothesis of decreased 
ANF synthesis in severe liver disease: a hypothesis based 
on the observation that increases in plasma ANF 
following volume stimulation is blunted in patients with 
decompensated cirrhosis (4). It seems an interesting task 
to reconcile this aspect of the Moreau et al. findings 
with the observation made by Gines et al. (5), of increased 
cardiac release of ANF in cirrhotic patients. 
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Frequent sporadic hepatitis E in st Africa evidenced by 
characterization of a virus-associated antigen in the stool 
Hepatitis E is the enterically transmitted form of non- 
A, non-B hepatitis in developing countries. During point- 
source epidemics, the clinical infection rate does not 
exceed 10% of people living in the area. There is a 
tendency for young adults to be infected and the rate 
seems to be higher in people from higher socioeconomic 
groups (1). These observations suggest that the infectious 
agent, hepatitis enteric virus (HEV), circulates in the 
population between epidemics and that the infection, 
presumably acquired early in life, may be associated 
with long-lasting immunity. Under these conditions, 
subjects affected by epidemics may represent a popula- 
tion which has not yet acquired immunity to HEV. In 
this case, sporadic cases of acute hepatitis E should 
occur between epidemics and also in developing coun- 
tries where epidemics are unknown. 
No epidemics of hepatitis E have yet been observed 
in Dakar where effective epidemiological control of 
hepatitis infections has been performed since 1978, in 
association with a vaccination campaign against hepati- 
tis B virus (HBV) (2). For these reasons, the Dakar area 
seems to be an appropriate location for the investigation 
of sporadic ases of HEV infection, as a potential starting 
point of possible pidemics in exposed countries. 
Thirty patients hospitalized in Dakar were selected. 
All had a diagnosis of acute infectious hepatitis with 
jaundice and elevated serum aminotransferase levels. All 
patients recovered within 6 months after the onset of 
symptoms. Classical IgM antibody tests were used for 
viral acute hepatitis diagnosis. The HEV-associated anti- 
gen was detected in the stools by an antigen capture 
ELISA technique recently developed by us, with IgM 
from an HEV-infected monkey on the solid phase and 
P-galactosidase-labelled IgG from the same source for 
antigen detection (3). A Fab-binding glycoprotein, 
termed ‘protein Fv’, discharged from the injured liver in 
stools and shown to induce false-positive r actions was 
systematically absorbed with insoluble monoclonal IgM 
(4). Serological markers of acute HAV, HBV, CMV and 
EBV infections could be detected in 4, 5, 1 and 1 case 
respectively. Four patients with acute hepatiti:. had HB- 
sAg in their serum and lacked anti-HBc IgM and anti- 
delta antibodies, and 3 patients had an anti-HCV anti- 
body. Thus, by a process of elimination, 12 patients 
seemed to be suffering from hepatitis E. 
HEV-AAg was found in 5 of 12 stools of patients 
without any infectious hepatitis markers and in 1 of 4 
patients with anti-HAV IgM. When the sera of patients 
with acute hepatitis of other etiologies were tested by 
blocking assay of the ELISA used for HEV-associated 
antigen detection, only serum from patients with hepati- 
tis E caused significant inhibition, thus confirming the 
specificity of the test. 
HEV appears to be implicated in at least 20% of acute 
infected hepatitis patients hospitalized in Dakar. Since 
the same antigen was previously found in an African 
epidemic (Ivory Coast) (5), the same agent would seem 
to be responsible for both sporadic and epidemic forms 
of hepatitis E in West Africa. 
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